Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (3): 266-272.doi: 10.11958/20230561
• Experimental Research • Previous Articles Next Articles
BAO Yaling1(), LEI Hui1,△(
), MA Jun2, Zhao Xinmei2
Received:
2023-04-23
Revised:
2023-07-13
Published:
2024-03-15
Online:
2024-03-13
Contact:
△E-mail: BAO Yaling, LEI Hui, MA Jun, Zhao Xinmei. Huangqi Yanghe Decoction regulates PI3K/AKT/NF-κB signaling pathway to promote wound healing in diabetes foot ulcer rats[J]. Tianjin Medical Journal, 2024, 52(3): 266-272.
CLC Number:
组别 | 第14天 | 第28天 |
---|---|---|
对照组 | 46.14±8.18 | 75.59±15.24 |
模型组 | 5.46±0.91a | 9.64±2.06a |
黄芪阳和汤低剂量组 | 12.49±2.62b | 26.24±4.59b |
黄芪阳和汤高剂量组 | 34.28±5.84bc | 51.28±8.05bc |
黄芪阳和汤高剂量+LY294002组 | 14.42±2.91d | 29.49±4.65d |
F | 147.653** | 113.521** |
Tab.1 Comparison of wound healing rate of rats between five groups
组别 | 第14天 | 第28天 |
---|---|---|
对照组 | 46.14±8.18 | 75.59±15.24 |
模型组 | 5.46±0.91a | 9.64±2.06a |
黄芪阳和汤低剂量组 | 12.49±2.62b | 26.24±4.59b |
黄芪阳和汤高剂量组 | 34.28±5.84bc | 51.28±8.05bc |
黄芪阳和汤高剂量+LY294002组 | 14.42±2.91d | 29.49±4.65d |
F | 147.653** | 113.521** |
组别 | 第14天 | 第28天 |
---|---|---|
对照组 | 5.62±1.15 | 5.27±1.28 |
模型组 | 24.66±4.28a | 22.05±4.06a |
黄芪阳和汤低剂量组 | 19.19±4.19b | 15.84±3.65b |
黄芪阳和汤高剂量组 | 13.58±2.94bc | 8.12±1.71bc |
黄芪阳和汤高剂量+LY294002组 | 18.80±3.17d | 14.19±2.61d |
F | 55.268** | 63.710** |
Tab.2 Comparison of FBG levels of rats between five groups
组别 | 第14天 | 第28天 |
---|---|---|
对照组 | 5.62±1.15 | 5.27±1.28 |
模型组 | 24.66±4.28a | 22.05±4.06a |
黄芪阳和汤低剂量组 | 19.19±4.19b | 15.84±3.65b |
黄芪阳和汤高剂量组 | 13.58±2.94bc | 8.12±1.71bc |
黄芪阳和汤高剂量+LY294002组 | 18.80±3.17d | 14.19±2.61d |
F | 55.268** | 63.710** |
组别 | 第14天 | 第28天 |
---|---|---|
对照组 | 36.84±7.35 | 40.43±8.41 |
模型组 | 22.57±4.11a | 24.86±5.37a |
黄芪阳和汤低剂量组 | 27.39±4.36b | 30.43±6.59b |
黄芪阳和汤高剂量组 | 31.48±5.85bc | 38.26±6.78bc |
黄芪阳和汤高剂量+LY294002组 | 26.85±4.51d | 31.86±5.49d |
F | 12.061** | 10.741** |
Tab.3 Comparison of TcpO2 levels in wound tissue of rats between five groups
组别 | 第14天 | 第28天 |
---|---|---|
对照组 | 36.84±7.35 | 40.43±8.41 |
模型组 | 22.57±4.11a | 24.86±5.37a |
黄芪阳和汤低剂量组 | 27.39±4.36b | 30.43±6.59b |
黄芪阳和汤高剂量组 | 31.48±5.85bc | 38.26±6.78bc |
黄芪阳和汤高剂量+LY294002组 | 26.85±4.51d | 31.86±5.49d |
F | 12.061** | 10.741** |
组别 | VEGF/(ng/L) | HIF-1α/(ng/L) | CRP/(μg/L) | IL-6/(ng/L) |
---|---|---|---|---|
对照组 | 18.15±4.39 | 35.18±7.56 | 0.76±0.15 | 12.56±2.10 |
模型组 | 6.42±1.27a | 18.51±4.08a | 4.53±1.06a | 27.83±4.47a |
黄芪阳和汤低剂量组 | 9.61±2.12b | 22.63±4.11b | 3.66±0.68b | 22.35±4.06b |
黄芪阳和汤高剂量组 | 14.43±2.26bc | 28.86±5.34bc | 2.49±0.47bc | 16.76±2.63bc |
黄芪阳和汤高剂量+LY294002组 | 10.28±2.20d | 23.67±4.81d | 3.54±0.52d | 21.81±4.19d |
F | 35.364** | 52.545** | 59.618** | 31.130** |
Tab.4 Comparison of serum VEGF, HIF-1α, CRP and IL-6 levels of rats between five groups
组别 | VEGF/(ng/L) | HIF-1α/(ng/L) | CRP/(μg/L) | IL-6/(ng/L) |
---|---|---|---|---|
对照组 | 18.15±4.39 | 35.18±7.56 | 0.76±0.15 | 12.56±2.10 |
模型组 | 6.42±1.27a | 18.51±4.08a | 4.53±1.06a | 27.83±4.47a |
黄芪阳和汤低剂量组 | 9.61±2.12b | 22.63±4.11b | 3.66±0.68b | 22.35±4.06b |
黄芪阳和汤高剂量组 | 14.43±2.26bc | 28.86±5.34bc | 2.49±0.47bc | 16.76±2.63bc |
黄芪阳和汤高剂量+LY294002组 | 10.28±2.20d | 23.67±4.81d | 3.54±0.52d | 21.81±4.19d |
F | 35.364** | 52.545** | 59.618** | 31.130** |
组别 | p-PI3K/PI3K | p-AKT/AKT | p-NF-κB p65/NF-κB p65 | IκB-α/β-actin |
---|---|---|---|---|
对照组 | 0.87±0.17 | 0.83±0.18 | 0.36±0.07 | 0.94±0.17 |
模型组 | 0.33±0.06a | 0.38±0.07a | 0.96±0.17a | 0.42±0.08a |
黄芪阳和汤低剂量组 | 0.49±0.07b | 0.52±0.09b | 0.77±0.11b | 0.57±0.09b |
黄芪阳和汤高剂量组 | 0.75±0.08bc | 0.65±0.11bc | 0.53±0.09bc | 0.68±0.11bc |
黄芪阳和汤高剂量+LY294002组 | 0.51±0.07d | 0.54±0.10d | 0.74±0.10d | 0.55±0.08d |
F | 57.906** | 52.909** | 50.316** | 41.263** |
Tab.5 Comparison of expression levels of PI3K/AKT/NF-κB signaling pathway related proteins in wound tissue of rats between five groups
组别 | p-PI3K/PI3K | p-AKT/AKT | p-NF-κB p65/NF-κB p65 | IκB-α/β-actin |
---|---|---|---|---|
对照组 | 0.87±0.17 | 0.83±0.18 | 0.36±0.07 | 0.94±0.17 |
模型组 | 0.33±0.06a | 0.38±0.07a | 0.96±0.17a | 0.42±0.08a |
黄芪阳和汤低剂量组 | 0.49±0.07b | 0.52±0.09b | 0.77±0.11b | 0.57±0.09b |
黄芪阳和汤高剂量组 | 0.75±0.08bc | 0.65±0.11bc | 0.53±0.09bc | 0.68±0.11bc |
黄芪阳和汤高剂量+LY294002组 | 0.51±0.07d | 0.54±0.10d | 0.74±0.10d | 0.55±0.08d |
F | 57.906** | 52.909** | 50.316** | 41.263** |
[1] | DAYYA D, O'NEILL O J, HUEDO-MEDINA T B, et al. Debridement of diabetic foot ulcers[J]. Adv Wound Care (New Rochelle), 2022, 11(12):666-686. doi:10.1089/wound.2021.0016. |
[2] | YANG S L, HU L Y, HAN R, et al. Neuropeptides,inflammation,biofilms,and diabetic foot ulcers[J]. Exp Clin Endocrinol Diabetes, 2022, 130(7):439-446. doi:10.1055/a-1493-0458. |
[3] | BIZ C, RUGGIERI P. Distal metatarsal osteotomies for chronic plantar diabetic foot ulcers[J]. Foot Ankle Clin, 2022, 27(3):545-566. doi:10.1016/j.fcl.2022.02.003. |
[4] | ALDANA P C, CARTRON A M, KHACHEMOUNE A. Reappraising diabetic foot ulcers:a focus on mechanisms of ulceration and clinical evaluation[J]. Int J Low Extrem Wounds, 2022, 21(3):294-302. doi:10.1177/1534734620944514. |
[5] | BOLTON L. Diabetic foot ulcer:treatment challenges[J]. Wounds, 2022, 34(6):175-177. doi:10.25270/wnds/2022.175177. |
[6] | 张荣荣, 王刚, 李梦虎. 中西医结合治疗糖尿病足的研究进展[J]. 中国中西医结合外科杂志, 2022, 28(5):740-743. |
ZHANG R R, WANG G, LI M L. Research progress in the treatment of diabetes foot with integrated traditional Chinese medicine and western medicine[J]. Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 2022, 28(5):740-743. doi:10.3969/j.issn.1007-6948.2022.05.029. | |
[7] | 陈晶, 刘欣欣, 李瑒, 等. 阳和汤的临床应用和基础研究进展[J]. 中华中医药学刊, 2022, 40(8):10-13. |
CHEN J, LIU X X, LI Y, et al. Research progress on indications of yanghe decoction(阳和汤)[J]. Chinese Archives of Traditional Chinese Medicine, 2022, 40(8):10-13. doi:10.13193/j.issn.1673-7717.2022.08.003. | |
[8] | 侯俊杰, 李大勇, 李世征, 等. 加味阳和汤治疗寒凝血瘀证下肢动脉硬化闭塞症的临床疗效及对血清ET-1、NO水平变化的影响[J]. 中华中医药学刊, 2019, 37(9):2093-2097. |
HOU J J, LI D Y, LI S Z, et al. Clinical efficacy of Jiawei Yanghe Decoction in treating lower extremity arteriosclerosis obliterans with cold coagulation and blood stasis syndrome and its effect on serum levels of ET-1 and NO[J]. Chinese Archives of Traditional Chinese Medicine, 2019, 37(9):2093-2097. doi:10.13193/j.issn.1673-7717.2019.09.010. | |
[9] | 王永灵, 廖明娟, 李琰, 等. 阳和汤加减结合负压技术治疗糖尿病足65例[J]. 中医外治杂志, 2020, 29(2):50-51. |
WANG Y L, LIAO M J, LI Y, et al. Treatment of 65 cases of diabetes foot with Yanghe decoction plus negative pressure technique[J]. Journal of External Therapy of Traditional Chinese Medicine, 2020, 29(2):50-51. doi:10.3969/j.issn.1006-978X.2020.02.026 | |
[10] | 牛文晶, 刘鹏, 王军. 基于网络药理学探讨黄芪-当归治疗糖尿病足的作用机制[J]. 中国中西医结合外科杂志, 2022, 28(2):252-257. |
NIU W J, LI P, WANG J. Mechanism of Huangqi-Danggui on diabetic foot based on network pharmacology[J]. Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 2022, 28(2):252-257. doi:10.3969/j.issn.1007-6948.2022.02.020. | |
[11] | 马艳春, 段莹, 胡建辉, 等. 黄芪治疗糖尿病及其并发症研究进展[J]. 中医药学报, 2022, 50(6):103-107. |
MA Y C, DUAN Y, HU J H, et al. Research progress of astragalus membranaceus in treating dm and its complications[J]. Acta Chinese Medicine and Pharmacology, 2022, 50(6):103-107. doi:10.19664/j.cnki.1002-2392.220141. | |
[12] | 张春玲, 陈露, 赵伟, 等. 基于转换生长因子-β1/Smad3信号通路观察丹黄散在糖尿病大鼠足溃疡创面愈合中的作用[J]. 中国临床药理学杂志, 2020, 36(21):3473-3476,3480. |
ZHANG C L, CHEN L, ZHAO W, et al. Danhuang powder promotes the wound healing of diabetic foot ulcer through transforming growth factor-β1/Smad3 signaling pathway in rats[J]. The Chinese Journal of Clinical Pharmacology, 2020, 36(21):3473-3476,3480. doi:10.13699/j.cnki.1001-6821.2020.21.019. | |
[13] | 贾湘隆, 徐旭英. 基于PI3K/AKT通路对回阳生肌膏促进糖尿病阴证疮面的微血管新生作用机制的初探[J]. 中华中医药杂志, 2020, 35(2):646-649. |
JIA X L, XU X Y. Preliminary mechanism study of Huiyang Shengji Ointment on affecting microvascular neogenesis of yin syndrome wound of diabetes based on PI3K/AKT pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(2):646-649. | |
[14] | 耿树军, 杨军, 莫爵飞. 132例缺血性糖尿病足溃疡患者局部病变的中医证候特征[J]. 中医杂志, 2022, 63(20):1958-1964. |
GENG S J, YANG J, MO J F. Characteristics of traditional Chinese medicine syndromes of local lesions in 132 patients with ischemic diabetic foot ulcer[J]. Journal of Traditional Chinese Medicine, 2022, 63(20):1958-1964. doi:10.13288/j.11-2166/r.2022.20.011. | |
[15] | 马斌, 柴智, 王金虹. 基于VOSviewer软件的黄芪治疗糖尿病研究文献计量分析[J]. 中国药房, 2020, 31(21):2634-2639. |
MA B, CHAI Z, WANG J H. Bibliometric analysis of astragalus membranaceus in the treatment of diabetes based on VOSviewer software[J]. China Pharmacy, 2020, 31(21):2634-2639. doi:10.6039/j.issn.1001-0408.2020.21.13. | |
[16] | 莫嘉敏, 颜晓东, 黄秀禄, 等. 下肢动脉病变和组织微循环状况对伤口负压治疗糖尿病足溃疡的疗效影响[J]. 中华糖尿病杂志, 2021, 13(3):209-214. |
MO J M, YAN X D, HUANG X L, et al. Effects of different lower extremity arterial disease and tissue microcirculation on negative pressure therapy for diabetic foot ulcer[J]. Chinese Journal of Diabetes, 2021, 13(3):209-214. doi:10.3760/cma.j.cn115791-20200713-00439. | |
[17] | 卓小玉, 陈晶, 田明, 等. 麻黄的化学成分与药理作用研究进展[J]. 中医药信息, 2021, 38(2):80-83. |
ZHUO X Y, CHEN J, TIAN M, et al. Research progress on chemical constituents and pharmacological effects of ephedra sinica[J]. Information on Traditional Chinese Medicine, 2021, 38(2):80-83. doi:10.19656/j.cnki.1002-2406.210216. | |
[18] | 肖先, 李春燕, 刘晓龙, 等. 甘草的主要化学成分及药理作用研究进展[J]. 新乡医学院学报, 2023, 40(3):280-285. |
XIAO X, LI C Y, LIU X L, et al. Research progress of main chemical constituents and pharmacological effects of Glycyrrhizae Radix et Rhizoma[J]. Journal of Xinxiang Medical University, 2023, 40(3):280-285. doi:10.7683/xxyxyxb.2023.03.016. | |
[19] | 马艳春, 胡建辉, 吴文轩, 等. 黄芪化学成分及药理作用研究进展[J]. 中医药学报, 2022, 50(4):92-95. |
MA Y C, HU J H, WU W X, et al. Research progress on chemical constituents and pharmacological effects of Radix Astragali[J]. Acta Chinese Medicine and Pharmacology, 2022, 50(4):92-95. doi:10.19664/j.cnki.1002-2392.220092. | |
[20] | AITCHESON S M, FRENTIU F D, HURN S E, et al. Skin wound healing:normal macrophage function and macrophage dysfunction in diabetic wounds[J]. Molecules, 2021, 26(16):4917. doi:10.3390/molecules26164917. |
[21] | WANG B S, MA X F, ZHANG C Y, et al. Astragaloside IV improves angiogenesis and promotes wound healing in diabetic rats via the activation of the SUMOylation Pathway[J]. Biomed Environ Sci, 2021, 34(2):124-129. doi:10.3967/bes2021.018. |
[22] | BASIRI R, SPICER M, LEVENSON C, et al. Improving dietary intake of essential nutrients can ameliorate inflammation in patients with diabetic foot ulcers[J]. Nutrients, 2022, 14(12):2393-2403. doi:10.3390/nu14122393. |
[23] | ZHAO K, JIANG Y P, ZHANG J, et al. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway[J]. Cell Cycle, 2022, 21(19):2091-2108. doi:10.1080/15384101.2022.2087277. |
[24] | LUO L, LIANG H, LIU L. Myristicin regulates proliferation and apoptosis in oxidized low-density lipoprotein-stimulated human vascular smooth muscle cells and human umbilical vein endothelial cells by regulating the PI3K/Akt/NF-κB signalling pathway[J]. Pharm Biol, 2022, 60(1):56-64. doi:10.1080/13880209.2021.2010775. |
[25] | WANG J, WU H, PENG Y X, et al. Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K/Akt pathways[J]. J Nanobiotechnology, 2021, 19(1):202-214. doi:10.1186/s12951-021-00942-0. |
[26] | ZHONG R, XIA T, WANG Y, et al. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway[J]. J Ethnopharmacol, 2022, 284(1):114777. doi:10.1016/j.jep.2021.114777. |
[1] | WANG Hongjun, SUN Xingxing, ZHANG Runlian. Study on the effect of Shengyang Yiwei Decoction on the immune function of rats with lung cancer based on PI3K/Akt/NF-κB signal pathway [J]. Tianjin Medical Journal, 2023, 51(7): 739-745. |
[2] | WANG Yi, WANG Haijiao, QI Lin, CUI Yujiao, CHEN Xiao, WANG Yan, HE Hongmei. Effects of Taohe Chengqi Decoction on PI3K/AKT/mTOR signaling pathway in ovary tissue of rats with polycystic ovary syndrome [J]. Tianjin Medical Journal, 2023, 51(6): 596-600. |
[3] | WANG Fei, ZHANG Xiaolei, LI Hanzhang, LI Yanan, HU Mengni, MA Jun. Effects of inhibiting PI3K/Akt/mTOR signaling pathway on autophagy, apoptosis and PD characteristic expression proteins in MPP+-treated SH-SY5Y cells [J]. Tianjin Medical Journal, 2023, 51(5): 449-453. |
[4] | XU Jing, SHEN Liyuan, QU Qinghua. Study on the mechanism of naringenin improving insulin resistance in rats with polycystic ovary syndrome based on PI3K/AKT pathway [J]. Tianjin Medical Journal, 2022, 50(3): 270-275. |
[5] | PENG Qing, WEN Yanjing△, LI Qian, LI Man, CHANG Meiying. Mechanism of PTEN/mTOR pathway in high glucose-induced apoptosis of human villous trophoblasts HTR-8/SVneo #br# [J]. Tianjin Medical Journal, 2022, 50(2): 120-124. |
[6] | CHEN Tao, LIU Li-yin, MA Xin-long, MA Jian-xiong, YU Run-ze, YU De-fu. The clinical study of Nice knot and skin distractor in the treatment of small and medium-sized skin and soft tissue defects [J]. Tianjin Medical Journal, 2021, 49(7): 765-768. |
[7] | CHEN Jiao, ZHANG Yan, ZHONG Yuan-yuan. MicroRNA-141 promotes the proliferation of ovarian granulosa cells in polycystic ovary syndrome through PI3K/Akt/mTOR signaling pathway [J]. Tianjin Medical Journal, 2021, 49(7): 673-677. |
[8] | ZHANG Ying-chao, MI Yan, WANG Cai-li. Advances of bone morphogenetic protein -7 in the pathogenesis of diabetic nephropathy [J]. Tianjin Medical Journal, 2021, 49(10): 1107-1111. |
[9] | LIU Si-jing, ZHANG Xiao, LI Yi, LUO Mao, WU Jian-bo, LI Rong△. The experimental study of platelet-rich plasma in repairing skin wound defects in mice #br# [J]. Tianjin Medical Journal, 2020, 48(6): 522-526. |
[10] | LI Xun, CHEN Jian-she, MEN Bo, LI Hui, CHEN Xiang, ZHANG Hui, HAO Gao-li, FAN Li-peng, ZHANG Xing-hua, DONG Ya-zhou. The protective effect of Yishen Tongluo Fang regulating PI3K/Akt pathway on the azoospermia/oligozoospermia model rats induced by cyclophosphamide#br# [J]. Tianjin Medical Journal, 2020, 48(12): 1159-1164. |
[11] | BAO Sa-ru-la, AN Gui-feng, SA Ru-la, SU-BU De-ge-ri-le. Effects of Hedyotis diffusa-sculellaria barbata components on biological behavior of adenocarcinoma of colon Lovo cells [J]. Tianjin Medical Journal, 2020, 48(10): 925-930. |
[12] | YUAN Le-yong, WANG Mei-fang. The effect and mechanism of OCCLUDIN on proliferation and apoptosis of SPC-A1 cells [J]. Tianjin Medical Journal, 2019, 47(7): 692-696. |
[13] | LIU Dan, TANG Zhi-ming, WU Fu-yun, ZHAO Hong-yan, KE Jing, XIANG Peng, JIN Jia-qing, LI Shan. The molecular mechanism of PDCD4 knockdown facilitating cisplatin resistance in gastric cancer through pAKT/pGSK3β pathway [J]. Tianjin Medical Journal, 2019, 47(5): 454-458. |
[14] | CHEN Yan-lin, GUO Ai, PENG Peng, ZHOU Mei, GU Zhong-ya, LIU Xiao-han, ZHANG Meng-zhe, DENG Yan-qiu. The protective effects of dulaglutide on AD-like neurodegenerative changes [J]. Tianjin Medical Journal, 2018, 46(7): 673-677. |
[15] | YANG Rui, XU Hua, WANG Bing, WANG Yong-qiang. The role of PI3K/AKT in acute kidney injury induced by abdominal sepsis in rats [J]. Tianjin Medical Journal, 2018, 46(6): 581-584. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||